Journal
JOURNAL OF EXPERIMENTAL MEDICINE
Volume 207, Issue 2, Pages 309-318Publisher
ROCKEFELLER UNIV PRESS
DOI: 10.1084/jem.20090880
Keywords
-
Categories
Funding
- National Institutes of Health (NIH) [RO1 AI052327, U19 AI062627, RO1 HL073284, RO1 AI079087]
- American Cancer Society [IRG-86-004]
- Leukemic and Lymphoma Society
Ask authors/readers for more resources
Phospholipase C gamma 1 (PLC gamma 1) is an important signaling effector of T cell receptor (TCR). To investigate the role of PLC gamma 1 in T cell biology, we generated and examined mice with T cell-specific deletion of PLC gamma 1. We demonstrate that PLC gamma 1 deficiency affects positive and negative selection, significantly reduces single-positive thymocytes and peripheral T cells, and impairs TCR-induced proliferation and cytokine production, and the activation of ERK, JNK, AP-1, NFAT, and NF-kappa B. Importantly, PLC gamma 1 deficiency impairs the development and function of FoxP3(+) regulatory T cells, causing inflammatory/autoimmune symptoms. Therefore, PLC gamma 1 is essential for T cell development, activation, and tolerance.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available